We are not your average site network. From feasibility to close-out, we are relentlessly focused on accelerating the clinical trial process to bring therapies to patients faster and more reliably than ever before.
Delivering Reliable Performance for:
Built for Speed
Built for Quality
Built to Deliver
for Your Next Trial
We don't wait for patients. We reach them—faster, smarter, and more effectively.
Standardized processes. Cleaner data. Studies that stay on track.
Denali retains specialized PIs with focused expertise where it matters most.
Access real communities. Gain more representative data.
Like the mountain we're named after, we represent the pinnacle—unwavering commitment to excellence, the courage to tackle complex challenges, and the vision to see beyond the horizon.
“True care”
My providers were very welcoming, considering, and knowledgeable. I look forward to my future care.
Steve L.
Patient
Proven
Top 3
Global Enrollers
92%
Protocol
Compliance Rate
40%
Faster Enrollment
vs. Industry Average
5x
Faster Study-Start-Up
*Based on "ClinicalTrials.gov" enrollment data, 2023-2024
Neurology & Psychiatry
Adult and pediatric CNS trials including depression, bipolar disorder, schizophrenia, ADHD, Alzheimer's, and Parkinson's disease.
Cardiovascular
Lipid disorders, hypertension, heart failure, Lp(a) reduction therapies, and cardiometabolic disease interventions.
Metabolic & Endocrine
Type 2 diabetes, obesity, NASH/MASH, thyroid disorders, and emerging GLP-1 agonist therapies.
Wound Care
Diabetic foot ulcers, venous leg ulcers, pressure injuries, and advanced wound healing technologies.
Vaccine
Vaccine trials across all phases, respiratory illness, and emerging infectious disease studies.
Internal Medicine
Gastroenterology, rheumatology, dermatology, and multi-system disorders requiring comprehensive patient management.
The sponsor was facing a six-month first-patient-in delay, with no sites activated nationwide and an urgent need to enroll 200 patients across 20 sites. With the study timeline at critical risk, the sponsor needed a site that could move quickly from activation to screening while still protecting data quality, eligibility standards, and participant readiness in a complex psychiatric trial.
Read More
A complex diabetic wound healing study faced significant enrollment pressure across the site network. The protocol required specialized wound assessment capabilities, careful subject qualification, and long-term retention in a patient population that is often difficult to engage consistently. Many sites struggled to identify qualified subjects and keep them active through the study duration.
Read More
